Publication: Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates
Issued Date
2004-07-01
Resource Type
ISSN
00664804
Other identifier(s)
2-s2.0-3042677988
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Antimicrobial Agents and Chemotherapy. Vol.48, No.7 (2004), 2581-2587
Suggested Citation
Sara Brega, Frédérique De Monbrison, Carlo Severini, Rachanee Udomsangpetch, Inge Sutanto, Paul Ruckert, François Peyron, Stéphane Picot Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates. Antimicrobial Agents and Chemotherapy. Vol.48, No.7 (2004), 2581-2587. doi:10.1128/AAC.48.7.2581-2587.2004 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/21619
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Real-time PCR for dihydrofolate reductase gene single-nucleotide polymorphisms in Plasmodium vivax isolates
Abstract
Mutations in the dhfr gene of Plasmodium vivax (pvdhfr) are associated with resistance to the antifolate antimalarial drugs. Polymorphisms in the pvdhfr gene were assessed by hybridization probe technology on the LightCycler instrument with 134 P. vivax-infected blood samples from Turkey (n = 24), Azerbaijan (n = 39), Thailand (n = 16), Indonesia (n = 53), and travelers (n = 19). Double mutations (S58R and S117N) or quadruple mutations (F57L/I, S58R, T61M, and S117N) in the pvdhfr genes were found in all Thai samples (100%). pvdhfr mutant-type alleles were significantly more common in samples from travelers (42%) than in those from patients from Indonesia (5%). Surprisingly, the pvdhfr single-mutation allele (S117N) was identified at a high frequency in parasites from Turkey and Azerbaijan (71 and 36%, respectively), where sulfadoxine-pyrimethamine is not recommended for the treatment of P. vivax malaria by the World Health Organization and the Malaria National Programs.